Molecular characteristics and advances in precision therapeutics for HR-positive and HER2-low breast cancer
Last Updated: Friday, October 2, 2026
Researchers provide a clinical review of HER2-low breast cancer, examining its epidemiological characteristics, biological basis, advances in diagnostic technologies, and evolving treatment strategies.